OPICAPONE'S ADDED BENEFIT AS A FIRST-LINE ADJUNCTIVE THERAPY TO LEVODOPA AND WHEN USED PROMPTLY FOR MOTOR FLUCTUATIONS IN PARKINSON'S DISEASE

被引:0
|
作者
Ebersbach, G. [1 ]
Ferreira, J. J. [2 ]
Antonini, A. [3 ]
Santos, A. [4 ]
Magalhaes, D. [5 ,6 ]
Rocha, J. -F. [5 ]
Soares-da-Silva, P. [4 ,6 ,7 ]
机构
[1] Beelitz Hosp, Movement Disorders Clin, Beelitz, Germany
[2] Univ Lisbon, Lab Clin Pharmacol & Therapeut, Fac Med, Lisbon, Portugal
[3] Univ Padua, Dept Neurosci, Padua, Italy
[4] BIAL Portela & Ca SA, Dept Res & Dev, Coronado, Portugal
[5] BIAL Portela & Ca SA, Med Affairs Dept, Coronado, Portugal
[6] Univ Porto, Porto, Portugal
[7] Univ Porto, MedInUP Ctr Drug Discovery & Innovat Med, Porto, Portugal
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A 244
引用
收藏
页码:E71 / E72
页数:2
相关论文
共 50 条
  • [1] Opicapone's added benefit as a first-line adjunctive therapy to levodopa and when used promptly in the motor fluctuations spectrum of Parkinson's disease: a post-hoc analysis of BIPARK-I and II
    Ebersbach, G.
    Ferreira, J.
    Antonini, A.
    Santos, A. -T.
    Magalhaes, D.
    Rocha, J-F.
    Soares-da-Silva, P.
    [J]. MOVEMENT DISORDERS, 2020, 35 : S445 - S445
  • [2] Pooled efficacy analysis of opicapone as adjunctive therapy to levodopa in patients with Parkinson's disease and motor fluctuations
    Ferreira, J.
    Lees, A.
    Santos, A.
    Lopes, N.
    Costa, R.
    Oliveira, C.
    Pinto, R.
    Nunes, T.
    Rocha, J. F.
    Soares-da-silva, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 144 - 144
  • [3] OPICAPONE AS FIRST-LINE ADJUNCTIVE LEVODOPA TREATMENT IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FLUCTUATIONS: BIPARK-I AND II COMBINED POST-HOC ANALYSIS
    Ferreira, J. J.
    Poewe, W.
    Antonini, A.
    Gama, H.
    Rocha, J. F.
    Magalhaes, D.
    Soares-da-Silva, P.
    [J]. PARKINSONISM & RELATED DISORDERS, 2020, 79 : E63 - E63
  • [4] Opicapone as adjunctive therapy to levodopa in patients with Parkinson's disease and motor fluctuations: Global impressions of change compared to placebo and entacapone
    Santos, A.
    Ferreira, J.
    Lees, A.
    Pinto, R.
    Lopes, N.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    [J]. MOVEMENT DISORDERS, 2015, 30 : S119 - S119
  • [5] Efficacy of opicapone as adjunctive therapy to levodopa in patients with Parkinson's disease and motor fluctuations: Analysis of pooled phase III studies
    Ferreira, J.
    Lees, A.
    Santos, A.
    Lopes, N.
    Costa, R.
    Oliveira, C.
    Pinto, R.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    [J]. MOVEMENT DISORDERS, 2015, 30 : S86 - S86
  • [6] The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II
    Rocha, Jose-Francisco
    Ebersbach, Georg
    Lees, Andrew
    Tolosa, Eduardo
    Ferreira, Joaquim J.
    Poewe, Werner
    Rascol, Olivier
    Stocchi, Fabrizio
    Antonini, Angelo
    Magalhaes, Diogo
    Gama, Helena
    Soares-da-Silva, Patricio
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
  • [7] When Do Levodopa Motor Fluctuations First Appear in Parkinson's Disease?
    Stocchi, Fabrizio
    Jenner, Peter
    Obeso, Jose A.
    [J]. EUROPEAN NEUROLOGY, 2010, 63 (05) : 257 - 266
  • [8] Opicapone as First-Line Adjunctive Levodopa Treatment in Parkinson's Disease Patients with Motor Fluctuations: Findings from BIPARK-I and II Combined Post-Hoc Analysis
    Ferreira, J. J.
    Poewe, W.
    Antonini, A.
    Gama, H.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-Da-Silva, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 189 - 190
  • [9] Opicapone as First-Line Adjunctive Levodopa Treatment in Parkinson's Disease Patients with Motor Fluctuations: Findings from BIPARK-I and II Combined Post-Hoc Analysis
    Ferreira, J.
    Poewe, W.
    Antonini, A.
    Gama, H.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-da-Silva, P.
    [J]. MOVEMENT DISORDERS, 2020, 35 : S447 - S448
  • [10] Opicapone for motor fluctuations in Parkinson's disease
    Devos, David
    Moreau, Caroline
    [J]. LANCET NEUROLOGY, 2016, 15 (02): : 127 - 128